Clinical Trials

Phase 1/2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06477523 2026-04-29

Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC

57 enrolled

SCLC, Extensive Stage

NCT06844422 2026-04-28

Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)

37 enrolled

Phase 1/2 Active not recruiting

Pancreatic Neoplasms

NCT04528680 2026-04-13

SC9/ABX

57 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT07354061 2026-04-01

TD-ENSEMBLE

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07477444 2026-03-20

HER-OIC

29 enrolled

Gastroesophageal Cancer

NCT02961101 2026-01-22

Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies

250 enrolled

Neoplasms, Recurrence

NCT07342725 2026-01-15

Phase Ib/II Study to Evaluate the Safety and Efficacy of IBI363 in Combination With Chemotherapy as Second-Line Therapy for Unresectable Locally Advanced or Metastatic Pancreatic Cancer

48 enrolled

Pancreatic Cancer Metastatic

NCT06596018 2025-12-30

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

96 enrolled

Breast Neoplasms

NCT02806258 2025-12-29

Néo-APBI-01

Phase 1/2 Terminated

362 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06529809 2025-12-24

Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer

50 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07291947 2025-12-18

PULSAR Combined With Immunotherapy and Chemotherapy

60 enrolled

Cholangiocarcinoma

NCT07261592 2025-12-03

Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer

29 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT06090864 2025-10-20

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

31 enrolled

Lymphoid

Hodgkin Disease, Recurrence

NCT07190027 2025-09-24

Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A Randomized Trial

246 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07161791 2025-09-09

Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer

12 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07131345 2025-08-20

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

Other solid neoplasmThoracic

55 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT06758544 2025-08-17

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer

18 enrolled

Pancreatic Neoplasms

NCT06941766 2025-04-30

Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors

20 enrolled

Intermediate Trophoblastic Tumor

NCT02649829 2025-04-29

MESODEC

GenitourinaryOther solid neoplasmThoracic

28 enrolled

Mesothelioma, Malignant, Wilms Tumor

NCT06866977 2025-03-10

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer

10 enrolled

Pancreatic Neoplasms

NCT00321698 2024-08-29

Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer

Phase 1/2 Terminated

25 enrolled 18 charts

Genitourinary

Prostatic Neoplasms

NCT05101616 2024-03-07

A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer

Phase 1/2 Suspended

100 enrolled

Stomach Neoplasms

NCT03757858 2024-02-07

Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases

Gynecologic

Neoplasm Metastasis, Neoplasms, Pelvic Neoplasms

NCT04558684 2024-01-03

Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer

Phase 1/2 Suspended

Rectal Neoplasms

NCT06173986 2023-12-18

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer

50 enrolled

Phase 1/2 Active not recruiting

Esophageal Squamous Cell Carcinoma

NCT03544736 2023-03-22

Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)

Esophageal Neoplasms

NCT04764513 2022-03-28

Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

LymphoidMyeloidOther hematologic neoplasm

20 enrolled

Lymphoma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05198856 2022-01-20

Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC

106 enrolled

Stomach Neoplasms

NCT04620954 2021-12-01

ORION-02

31 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial

NCT02046187 2021-06-16

Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma

Phase 1/2 Terminated

14 enrolled

CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT03985891 2020-12-17

JSFOL

Colonic Neoplasms

NCT04410887 2020-06-01

Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC)

Stomach Neoplasms

NCT04333004 2020-04-03

Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy

Gut Microbiota

NCT02496520 2020-02-21

DEND/TIA

6 enrolled

CNSSarcoma

Sarcoma, Central Nervous System Neoplasms

NCT01490996 2020-01-31

CUFOX

41 enrolled

Colonic Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT03175341 2018-06-27

Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer

Breast Neoplasms

NCT01975454 2018-04-19

Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer

62 enrolled

Colorectal Neoplasms

NCT03453255 2018-03-05

DCHA as Postremission Therapy for AML With t(8;21)

Other hematologic neoplasm

120 enrolled

Leukemia, Myeloid, Acute

NCT01211275 2017-02-28

N08CPA

Other solid neoplasmThoracic

32 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT00256815 2014-02-11

Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00256841 2014-01-29

Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy

Phase 1/2 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT01843049 2013-04-30

Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer

Esophageal Neoplasms

NCT00179816 2010-10-11

Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors